Detalhe da pesquisa
1.
Influence of migrant background on patient preference and expectations in breast and gynecological malignancies (NOGGO-expression V study): results of a prospective multicentre study in 606 patients in Germany.
BMC Cancer
; 21(1): 1018, 2021 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34511112
2.
ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee.
Ann Oncol
; 31(11): 1449-1461, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32763452
3.
ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee.
Ann Oncol
; 31(11): 1435-1448, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32763453
4.
Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study.
Ann Oncol
; 30(8): 1370-1380, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31150059
5.
Development and validation of a nomogram to predict recurrence and melanoma-specific mortality in patients with negative sentinel lymph nodes.
Br J Surg
; 106(3): 217-225, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30307046
6.
Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II.
Ann Oncol
; 29(10): 2105-2114, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30412221
7.
Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial.
Ann Oncol
; 27(8): 1585-93, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27084954
8.
Circulating tumour cells as tumour biomarkers in melanoma: detection methods and clinical relevance.
Ann Oncol
; 26(1): 33-39, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24907634
9.
TEMHEAD: a single-arm multicentre phase II study of temsirolimus in platin- and cetuximab refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) of the German SCCHN Group (AIO).
Ann Oncol
; 26(3): 561-7, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25527417
10.
Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol
; 30(12): 1884-1901, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31566661
11.
Detection of circulating tumor cells for prediction of recurrence after adjuvant chemoradiation in locally advanced squamous cell carcinoma of the head and neck.
Ann Oncol
; 25(10): 2042-2047, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25057171
12.
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial.
Ann Oncol
; 25(3): 742-746, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24510314
13.
Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part).
Ann Oncol
; 25(3): 682-688, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24567516
14.
Phase I, dose-finding study of AZD8931, an inhibitor of EGFR (erbB1), HER2 (erbB2) and HER3 (erbB3) signaling, in patients with advanced solid tumors.
Invest New Drugs
; 32(1): 145-53, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23589215
15.
Phase II study of cetuximab in combination with docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck after platinum-containing therapy: a multicenter study of the Arbeitsgemeinschaft Internistische Onkologie.
Oncology
; 84(5): 284-9, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23445718
16.
[Diagnosis of and therapy for choroidal melanoma]. / Diagnostik und Therapie choroidaler Melanome.
Klin Monbl Augenheilkd
; 230(10): 1005-19, 2013 Oct.
Artigo
em Alemão
| MEDLINE | ID: mdl-24046188
17.
Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumors.
ESMO Open
; 7(2): 100447, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35397434
18.
Phase I/II trial of cilengitide with cetuximab, cisplatin and 5-fluorouracil in recurrent and/or metastatic squamous cell cancer of the head and neck: findings of the phase I part.
Br J Cancer
; 104(11): 1691-6, 2011 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21540865
19.
appendix 2: Cutaneous melanoma (2): eUpdate published online September 2016 (http://www.esmo.org/Guidelines/Melanoma).
Ann Oncol
; 27(suppl 5): v136-v137, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27664250
20.
The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN).
Ann Oncol
; 22(8): 1878-85, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21525401